Improved renal function in liver transplant recipients treated for hepatitis C virus with a sustained virological response and mild chronic kidney disease

Liver Transplantation

Volumn 20, Issue 1, 2014, Pages 25-34

  Blé, Michel ^a,b   Aguilera, Victoria ^a,b   Rubín, Angel ^a,b   García Eliz, María ^a,b   Vinaixa, Carmen ^a,b   Prieto, Martín ^a,b   Berenguer, Marina ^a,b,c  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; DIETARY INTAKE; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODIFICATION OF DIET IN RENAL DISEASE; PRIORITY JOURNAL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; KIDNEY; KIDNEY FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RENAL INSUFFICIENCY; RENAL INSUFFICIENCY, CHRONIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 84896542397     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23756     Document Type: Article

References (25)

1. Berenguer M, Charco R, Manuel Pascasio J, Ignacio Herrero J,. Spanish Society of Liver Transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation. Liver Int 2012; 32: 712-731.
2. Samuel D, Forns X, Berenguer M, Trautwein C, Burroughs A, Rizzetto M, Trepo C,. Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006). J Hepatol 2006; 45: 127-143.
3. Berenguer M,. Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin. J Hepatol 2008; 49: 274-287.
4. Carriõn JA, Navasa M, García-Retortillo M, García-Pagan JC, Crespo G, Bruguera M, et al. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study. Gastroenterology 2007; 132: 1746-1756.
5. Bizollon T, Pradat P, Mabrut JY, Chevallier M, Adham M, Radenne S, et al. Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C. Am J Transplant 2005; 5: 1909-1913.
6. Berenguer M, Palau A, Aguilera V, Rayõn JM, Juan FS, Prieto M,. Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation. Am J Transplant 2008; 8: 679-687.
7. Mutimer D,. Understanding the switchbacks: the impact of direct antivirals on the minimization of hepatitis C virus recurrence after transplantation. Liver Transpl 2012; 18 (suppl 2): S47-S51.
8. Coilly A, Roche B, Samuel D,. Current management and perspectives for HCV recurrence after liver transplantation. Liver Int 2013; 33 (suppl 1): 56-62.
9. O'Riordan A, Dutt N, Cairns H, Rela M, O'Grady JG, Heaton N, Hendry BM,. Renal biopsy in liver transplant recipients. Nephrol Dial Transplant 2009; 24: 2276-2282.
10. Weber ML, Ibrahim HN, Lake JR,. Renal dysfunction in liver transplant recipients: evaluation of the critical issues. Liver Transpl 2012; 18: 1290-1301.
11. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940.
12. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100.
13. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, Collins AJ,. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489-495.
14. Poggio ED, Nef PC, Wang X, Greene T, Van Lente F, Dennis VW, Hall PM,. Performance of the Cockcroft-Gault and Modification of Diet in Renal Disease equations in estimating GFR in ill hospitalized patients. Am J Kidney Dis 2005; 46: 242-252.
15. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al.; for Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
16. Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB,. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 2004; 10: 301-309.
17. Morales JM, Marcén R, Andres A, Domínguez-Gil B, Campistol JM, Gallego R, et al. Renal transplantation in patients with hepatitis C virus antibody. A long national experience. NDT Plus 2010; 3 (suppl 2): ii41-ii46.
18. Cohen AJ, Stegall MD, Rosen CB, Wiesner RH, Leung N, Kremers WK, Zein NN,. Chronic renal dysfunction late after liver transplantation. Liver Transpl 2002; 8: 916-921.
19. Karie-Guigues S, Janus N, Saliba F, Dumortier J, Duvoux C, Calmus Y, et al. Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study. Liver Transpl 2009; 15: 1083-1091.
20. Sharma P, Welch K, Eikstadt R, Marrero JA, Fontana RJ, Lok AS,. Renal outcomes after liver transplantation in the Model for End-Stage Liver Disease era. Liver Transpl 2009; 15: 1142-1148.
21. Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F,. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study. Dig Liver Dis 2009; 41: 350-356.
22. Butt AA, Wang X, Fried LF,. HCV infection and the incidence of CKD. Am J Kidney Dis 2011; 57: 396-402.
23. Satapathy SK, Lingisetty CS, Williams S,. Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection. Hepatol Int 2012; 6: 369-378.
24. Locatelli F, Nissenson AR, Barrett BJ, Walker RG, Wheeler DC, Eckardt KU, et al. Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2008; 74: 1237-1240.
25. Saliba F, De Simone P, Nevens F, De Carlis L, Metselaar HJ, Beckebaum S, et al.; for H2304 Study Group. Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study. Am J Transplant 2013; 13: 1734-1745.